Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Fountzilas, G' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 136 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Skarlos, DV; Samantas, E; Briassoulis, E; Panoussaki, E; Pavlidis, N; Kalofonos, HP; Kardamakis, D; Tsiakopoulos, E; Kosmidis, P; Tsavdaridis, D; Tzitzikas, J; Tsekeris, P; Kouvatseas, G; Zamboglou, N; Fountzilas, G
      Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)

      ANNALS OF ONCOLOGY
    2. Razis, ED; Fountzilas, G
      Paclitaxel: Epirubicin in metastatic breast cancer - a review

      ANNALS OF ONCOLOGY
    3. Fountzilas, G; Tsavdaridis, D; Kalogera-Fountzila, A; Christodoulou, C; Timotheadou, E; Kalofonos, C; Kosmidis, P; Adamou, A; Papakostas, P; Gogas, H; Stathopoulos, G; Razis, E; Bafaloukos, D; Skarlos, D
      Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer - A Hellenic Cooperative Oncology Group phase IIstudy

      ANNALS OF ONCOLOGY
    4. Razis, E; Dimopoulus, AM; Bafaloukos, D; Papadimitriou, C; Kalogera-Fountzila, A; Kalofonos, H; Briassoulis, E; Samantas, E; Keramopoulos, A; Pavlidis, N; Kosmidis, P; Fountzilas, G
      Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer

      CANCER INVESTIGATION
    5. Fountzilas, G; Papadimitriou, C; Dafni, U; Bafaloukos, D; Skarlos, D; Moulopouos, LA; Razis, E; Kalofonos, HP; Aravantinos, G; Briassoulis, E; Papakostas, P; Abela, K; Gogas, E; Kosmidis, P; Pavlidis, N; Dimopoulos, MA
      Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: A randomized study conducted by the Hellenic Cooperative Oncology Group

      JOURNAL OF CLINICAL ONCOLOGY
    6. Giatromanolaki, A; Stathopoulos, GP; Koukourakis, MI; Rigatos, S; Vrettou, E; Kittas, C; Fountzilas, G; Sivridis, E
      Angiogenesis and apoptosis-related protein (p53, bcl-2, and bax) expression versus response of gastric adenocarcinomas to paclitaxel and carboplatin chemotherapy

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    7. Pectasides, D; Kalofonos, HP; Samantas, E; Nicolaides, C; Papacostas, P; Onyenadum, A; Visvikis, A; Skarlos, D; Fountzilas, G
      An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic Co-Operative Oncology Group

      ANTICANCER RESEARCH
    8. Giatromanolaki, A; Sivridis, E; Stathopoulos, GP; Fountzilas, G; Kalofonos, HP; Tsamandas, A; Vrettou, E; Scopa, C; Polychronidis, A; Simopoulos, K; Koukourakis, MI
      Bax protein expression in colorectal cancer: Association with p53, bcl-2 and patterns of relapse

      ANTICANCER RESEARCH
    9. Fountzilas, G; Papadimitriou, C; Aravantinos, G; Nicolaides, C; Stathopoulos, G; Bafaloukos, D; Kalofonos, H; Ekonomopoulos, T; Skarlos, D; Pavlidis, N; Dimopoulos, AM
      Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer

      ONCOLOGY
    10. Daniilidis, J; Constantinidis, J; Fountzilas, G
      Combined chemoradiotherapy in locally advanced nasopharyngeal carcinoma

      HNO
    11. Briasoulis, E; Andreopoulou, E; Tolis, CF; Bairaktari, E; Katsaraki, A; Dimopoulos, MA; Fountzilas, G; Seferiadis, G; Pavlidis, N
      G-CSF induces elevation of circulating CA 15-3 in breast carcinoma patients treated in an adjuvant setting

      CANCER
    12. Koukourakis, MI; Giatromanolaki, A; Fountzilas, G; Sivridis, E; Gatter, KC; Harris, AL
      Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy

      CLINICAL CANCER RESEARCH
    13. Kosmidis, P; Mylonakis, N; Skarlos, D; Samantas, E; Dimopoulos, M; Papadimitriou, C; Kalophonos, C; Pavlidis, N; Nikolaidis, C; Papaconstantinou, C; Fountzilas, G
      Paclitaxel (175 mg/m(2)) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m(2))plus carboplatin (6 AUG) in advanced non-small-cell lung cancer (NSCLC): A multicenter randomized trial

      ANNALS OF ONCOLOGY
    14. Nicolaides, C; Dimopoulos, MA; Samantas, E; Bafaloukos, D; Kalofonos, C; Fountzilas, G; Razi, E; Kosmidis, P; Pavlidis, N
      Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology Group

      ANNALS OF ONCOLOGY
    15. Janinis, J; Papakostas, P; Samelis, G; Skarlos, D; Papagianopoulos, P; Fountzilas, G
      Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study

      ANNALS OF ONCOLOGY
    16. Samantas, E; Kalofonos, H; Linardou, H; Nicolaides, C; Mylonakis, N; Fountzilas, G; Kosmidis, P; Skarlos, D
      Phase II study of pegylated liposomal doxorubicin: Inactive in recurrent small-cell lung cancer - A Hellenic Cooperative Oncology Group Study

      ANNALS OF ONCOLOGY
    17. Fountzilas, G; Nicolaides, C; Bafaloukos, D; Kalogera-Fountzila, A; Kalofonos, H; Samelis, G; Aravantinos, G; Pavlidis, N
      Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: A Hellenic cooperative oncology group phase II study

      CANCER INVESTIGATION
    18. Briasoulis, E; Kalofonos, H; Bafaloukos, D; Samantas, E; Fountzilas, G; Xiros, N; Skarlos, D; Christodoulou, C; Kosmidis, F; Pavlidis, N
      Carboplatin plus paclitaxel in unknown primary carcinoma: A phase II Hellenic Cooperative Oncology Group study

      JOURNAL OF CLINICAL ONCOLOGY
    19. Janinis, J; Giannakakis, T; Athanasiades, A; Fountzilas, G; Bafaloukos, D; Kosmidis, P; Nikolaides, K; Pavlidis, N; Skarlos, D
      A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study

      TUMORI
    20. Giatromanolaki, A; Koukourakis, MI; Sivridis, E; Thorpe, PE; Brekken, RA; Konstantinos, S; Fountzilas, G; Gatter, KC; Harris, AL
      Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas

      CLINICAL & EXPERIMENTAL METASTASIS
    21. Giatromanolaki, A; Ourakis, MIK; Sivridis, E; Fountzilas, G
      c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cellcarcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival

      ANTICANCER RESEARCH
    22. Economopoulos, T; Dimopoulos, MA; Foudoulakis, A; Nikolaidis, C; Tsatalas, C; Pectacides, D; Rontogianni, D; Papageorgiou, E; Fountzilas, G
      Burkitt's lymphoma in Greek adults - A study of the Hellenic co-operative oncology group

      LEUKEMIA RESEARCH
    23. Kosmidis, P; Mylonakis, N; Dimopoulos, A; Pavlidis, N; Fountzilas, G; Samantas, E; Dimitriadis, K; Kalophonos, C; Tsavdaridis, D; Skarlos, D
      Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: A phase III randomized study. Preliminary results

      SEMINARS IN ONCOLOGY
    24. Pectasides, D; Economopoulos, T; Kouvatseas, G; Antoniou, A; Zoumbos, Z; Aravantinos, G; Tsatalas, C; Halikia, A; Nikolaides, C; Kiamouris, C; Pappa, E; Pavlidis, N; Skarlos, D; Fountzilas, G; Dimopoulos, MA
      Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: The Hellenic Cooperative Oncology Group experience

      ONCOLOGY
    25. Fountzilas, G; Zisiadis, A; Dafni, U; Konstantaras, C; Hatzitheoharis, G; Papavramidis, S; Bousoulegas, A; Basdanis, G; Giannoulis, E; Dokmetzioglou, J; Katsohis, C; Nenopoulou, E; Karvounis, N; Briassoulis, E; Aravantinos, G; Kosmidis, P; Skarlos, D; Pavlidis, N
      Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvanttreatment, in patients with high-risk colon cancer - A randomized phase III study conducted by the Hellenic Cooperative Oncology Group

      ONCOLOGY
    26. Aravantinos, G; Skarlos, DV; Kosmidis, P; Georgoulias, V; Sgouros, I; Bafaloukos, D; Androulakis, N; Florou, S; Fountzilas, G
      Irinotecan (CPT-11) in patients with advanced colorectal cancer previouslytreated with 5-fluorouracil-based chemotherapy

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    27. Fountzilas, G; Zisiadis, A; Dafni, U; Konstantaras, C; Hatzitheoharis, G; Liaros, A; Athanassiou, E; Dombros, N; Dervenis, C; Basdanis, G; Gamvros, O; Souparis, A; Briasoulis, E; Samantas, E; Kappas, A; Kosmidis, P; Skarlos, D; Pavlidis, N
      Postoperative radiation and concomitant bolus fluorouracil with or withoutadditional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: A randomized phase III study conducted by the Hellenic Cooperative Oncology Group

      ANNALS OF ONCOLOGY
    28. Briasoulis, E; Karavasilis, V; Anastasopoulos, D; Tzamakou, E; Fountzilas, G; Rammou, D; Kostadima, V; Pavlidis, N
      Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration

      ANNALS OF ONCOLOGY
    29. Fountzilas, G; Stathopoulos, G; Nicolaides, C; Kalogera-Fountzila, A; Kalofonos, H; Nikolaou, A; Bacoyiannis, C; Samantas, E; Papadimitriou, C; Kosmidis, P; Daniilidis, J; Pavlidis, N
      Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group

      ANNALS OF ONCOLOGY
    30. Dimopoulos, MA; Bakoyannis, C; Georgoulias, V; Papadimitriou, C; Moulopoulos, LA; Deliveliotis, C; Karayannis, A; Varkarakis, I; Aravantinos, G; Zervas, A; Pantazopoulos, D; Fountzilas, G; Bamias, A; Kyriakakis, Z; Anagnostopoulos, A; Giannopoulos, A; Kosmidis, P
      Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology Group

      ANNALS OF ONCOLOGY
    31. Papadimitriou, CA; Sarris, K; Moulopoulos, LA; Fountzilas, G; Anagnostopoulos, A; Voulgaris, Z; Gika, D; Giannakoulis, N; Diakomanolis, E; Dimopoulos, MA
      Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix

      JOURNAL OF CLINICAL ONCOLOGY
    32. Xiros, N; Economopoulos, T; Fountzilas, G; Pavlidis, N; Samantas, E; Raptis, S
      A phase-II study with idarubicin, etoposide and prednisone (IVPP), in patients with refractory or early relapsed intermediate or high grade non-Hodgkin's lymphoma

      HAEMATOLOGICA
    33. Makrantonakis, P; Pectasides, D; Aggouridakis, C; Visvikis, A; Daniilidis, J; Fountzilas, G
      Squamous cell carcinoma antigen, circulating immune complexes, and immunoglobulins in monitoring squamous cell carcinoma of head and neck - A study of the Hellenic Co-Operative Oncology Group (HeCOG)

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    34. Skarlos, DV; Samantas, E; Pectasides, D; Pavlidis, N; Kalofonos, C; Klouvas, G; Panoussaki, E; Tsiakopoulos, E; Poulakis, N; Fountzilas, G
      Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis - A study of the Hellenic Cooperative Oncology Group

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    35. Pectasides, D; Tsavdaridis, D; Aggouridaki, C; Tsavdaridou, V; Visvikis, A; Tsatalas, K; Fountzilas, G
      Effects on blood coagulation of adjuvant CNF (Cyclophosphamide, Novantrone, 5-Fluorouracil) chemotherapy in stage II breast cancer patients

      ANTICANCER RESEARCH
    36. Samantas, E; Skarlos, DV; Pectasides, D; Nicolaides, P; Kalofonos, H; Mylonakis, N; Vardoulakis, T; Kosmidis, P; Pavlidis, N; Fountzilas, G
      Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer

      LUNG CANCER
    37. Fountzilas, G; Karavelis, A; Capizzello, A; Kalogera-Fountzila, A; Karkavelas, G; Zamboglou, N; Selviaridis, P; Foroglou, G; Tourkantonis, A
      Radiation and concomitant weekly administration of paclitaxel in patients with glioblastoma multiforme. A phase II study

      JOURNAL OF NEURO-ONCOLOGY
    38. Pectasides, D; Aravantinos, G; Visvikis, A; Bakoyiannis, C; Halikia, A; Kalofonos, C; Kosmidis, P; Skarlos, D; Fountzilas, G
      Platinum-based chemotherapy of primary extragonadal germ cell tumours: TheHellenic Cooperative Oncology Group experience

      ONCOLOGY
    39. Giatromanolaki, A; Koukourakis, MI; Georgoulias, V; Gatter, KC; Harris, AL; Fountzilas, G
      Angiogenesis vs. response after combined chemoradiotherapy of squamous cell head and neck cancer

      INTERNATIONAL JOURNAL OF CANCER
    40. DIMOPOULOS MA; PAPADOPOULOU M; ANDREOPOULOU E; PAPADIMITRIOU C; PAVLIDIS N; ARAVANTINOS G; ASPROPOTAMITIS A; FOUNTZILAS G; MICHALAS S; PECTASIDES D
      FAVORABLE OUTCOME OF OVARIAN GERM-CELL MALIGNANCIES TREATED WITH CISPLATIN OR CARBOPLATIN BASED CHEMOTHERAPY - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY

      European journal of cancer
    41. ECONOMOPOULOS T; FOUNTZILAS G; KOSTOUROU A; DANIILIDIS J; PAVLIDIS N; NICOLAOU A; MALLOU S; DERVENOULAS J; STATHAKIS M
      PRIMARY EXTRANODAL NON-HODGKINS-LYMPHOMA OF THE HEAD AND NECK IN ADULTS - A CLINICOPATHOLOGICAL COMPARISON BETWEEN TONSILLAR LYMPHOMAS

      European journal of cancer
    42. ELISAF M; BAIRAKTARI E; NICOLAIDES C; FOUNTZILAS G; TZALLAS C; TSOLAS O; SIAMOPOULOS K; PAVLIDIS N
      DO LH-RH ANALOGS INDUCE EFFECTS SIMILAR TO TAMOXIFEN ON SERUM-LIPID PARAMETERS IN PREMENOPAUSAL WOMEN WITH BREAST-CANCER - A PROSPECTIVE-STUDY

      NMCD. Nutrition Metabolism and Cardiovascular Diseases
    43. FOUNTZILAS G; DIMOPOULOS AM; PAPADIMITRIOU C; KALOGERAFOUNTZILA A; ARAVANTINOS G; BAFALOAKOS D; ATHANASSIADES A; NICOLAIDES C; KERAMOPOULOS A; PAVLIDIS N; KOSMIDIS P; SKARLOS D
      FIRST-LINE CHEMOTHERAPY WITH PACLITAXEL BY 3-HOUR INFUSION AND CARBOPLATIN IN ADVANCED BREAST-CANCER (FINAL REPORT) - A PHASE-II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP

      Annals of oncology
    44. FOUNTZILAS G; BAFALOUKOS D; NIKOLAIDES C; ARAVANTINOS G; STATHOPOULOS G; APOSTOLIDOU K; KALOFONOS H; KOSMIDIS P; PAVLIDIS N
      DOCETAXEL (D) AND GEMCITABINE (G) IN ANTHRACYCLINE-RESISTANT ADVANCEDBREAST-CANCER (AR-ABC)

      Annals of oncology
    45. JANINIS J; FOUNTZILAS G; PAPAKOSTAS P; EFSTATHIOU E; VALAGOUTI D; SKARLOS D
      A PHASE-II STUDY OF WEEKLY OXALIPLATIN AND HIGH-DOSE 5-FU WITH LCV AS2ND LINE THERAPY IN PATIENTS WITH ADVANCED COLORECTAL-CANCER

      Annals of oncology
    46. PAPAKOSTAS P; RIGATOS S; STATHOPOULOS GP; SAMELIS G; POLYZOS A; FOUNTZILAS G
      2ND LINE CHEMOTHERAPY WITH PACLITAXEL AND CARBOPLATIN IN ADVANCED GASTRIC-CANCER

      Annals of oncology
    47. ARAVANTINOS G; FOUNTZILAS G; KOSMIDES P; STATHOPOULOS GP; PAVLIDIS N; DIMOPOULOS MA; BAFALOUKOS D; PAPAKOSTAS P; PAPADIMITRIOU C; NIKOLAIDES G; SKARLOS DV
      COMBINATION PACLITAXEL PLUS CARBOPLATIN VERSUS PACLITAXEL WITH ALTERNATING CARBOPLATIN AND CISPLATIN AS FIRST LINE TREATMENT FOR ADVANCED OVARIAN-CANCER (AOC)

      Annals of oncology
    48. DIMOPOULOS MA; PAPADOPOULOU M; ANDREOPOULOU E; PAPADIMITRIOU C; PAVLIDIS N; ARAVANTINOS G; ASPROPORAMITIS A; ANAGNOSTOPOULOS A; FOUNTZILAS G; ATHANASSIADES P; PECTACIDES D
      FAVORABLE OUTCOME OF OVARIAN GERM-CELL MALIGNANCIES TREATED WITH CISPLATIN OR CARBOPLATIN-BASED CHEMOTHERAPY

      Annals of oncology
    49. PAPADIMITRIOU C; DIMOPOULOS MA; MOULOPOULOS L; SARRIS K; FOUNTZILAS G; VOULGARIS Z; ANAGNOSTOPOULOS A; ATHANASSIADES P; STAMATELOPOULOS S
      A PHASE-II TRIAL OF PACLITAXEL AND CISPLATIN IN THE TREATMENT OF METASTATIC CARCINOMA OF THE UTERINE CERVIX

      Annals of oncology
    50. SAMANTAS E; FOUNTZILAS G; PANOUSSAKI E; BRIASOULIS E; PAVLIDIS N; KALOFONOS G; KARDAMAKIS D; TSIAKOPOULOS E; PALAMIDAS F; SKARLOS D
      RANDOMIZED COMPARISON OF EARLY VS LATE TWICE-DAILY CHEST IRRADIATION CONCURRENTLY WITH CHEMOTHERAPY IN LIMITED DISEASE SMALL-CELL LUNG-CANCER (LD,SCLC)

      Annals of oncology
    51. XIROS N; ECONOMOPOULOS T; FOUNTZILAS G; PAVLIDES N; NICOLAIDES C; SAMANTAS E; MELLOU S; PAPAGEORGIOU E; STATHOPOULOU E; RAPTIS SA
      A PHASE-II STUDY WITH IDARUBICIN VEPESIDE AND PREDNISONE (IDA VP/P), IN PATIENTS WITH REFRACTORY OR EARLY RELAPSED INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA/

      Annals of oncology
    52. BAFALOUKOS D; SKARLOS D; FOUNTZILAS G; DIMOPOULOS AM; KOSMIDIS P
      PACLITAXEL IN COMBINATION WITH DOXORUBICIN IN ADVANCED ADULT SOFT-TISSUE SARCOMA (ASTS) - A HELLENIC COOPERATIVE PHASE-II STUDY

      Annals of oncology
    53. BRIASOULIS E; KARAVASILIS V; ANASTASOPOULOS D; FOUNTZILAS G; TZAMAKOU E; RAMMOU D; PAVLIDIS N
      PHASE-I TRIAL OF WEEKLY ADMINISTRATION OF DOCETAXEL IN MINIMALLY PRETREATED CANCER-PATIENTS - A FEASIBILITY AND CUMULATIVE TOXICITY STUDY

      Annals of oncology
    54. SAMANTAS E; KIAMOURIS C; KALOFONOS H; KOUROUSIS H; ARAVANTINOS G; JANINIS J; ANDROULAKIS N; KOURMPANIS V; FOUNTZILAS G; SKARLOS D
      PHASE-II STUDY WITH DOCETAXEL IN PRETREATED PATIENTS WITH SMALL-CELL LUNG-CANCER

      Annals of oncology
    55. FOUNTZILAS G; DIMOPOULOS M; PAPADIMITRIOU C; ARAVANTINOS G; BRIASSOULIS E; BAFALOUKOS D; PAPAKOSTAS P; PAVLIDIS N; SKARLOS D
      DOSE-DENSE SEQUENTIAL ADJUVANT CHEMOTHERAPY WITH EPIRUBICIN, PACLITAXEL AND CMF IN PATIENTS WITH OPERABLE BREAST-CANCER AND GREATER-THAN-OR-EQUAL-TO-10 POSITIVE AXILLARY NODES

      Annals of oncology
    56. FOUNTZILAS G; ATHANASSIADES A; PAPADIMITRIOU V; DIMOPOULOS MA; BAFALOUKOS D; ARAVANTINOS G; NICOLAIDES C; KALOFONOS HR; PAPAKOSTAS P; XIROS N; RAZI E
      PACLITAXEL AND CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY FOR ADVANCED BREAST-CANCER

      Oncology
    57. NICOLAIDES C; GIANNAKAKIS T; SKARLOS D; ATHANASSIADIS A; FOUNTZILAS G; DAMIGOS D; PAVLIDIS N
      TROPISETRON IN THE PREVENTION OF ACUTE NAUSEA AND VOMITING IN PATIENTS TREATED WITH HIGH-DOSE EPIRUBICIN

      Journal of experimental & clinical cancer research
    58. Giatromanolaki, A; Fountzilas, G; Koukourakis, MI; Arapandoni, P; Theologi, V; Kakolyris, S; Georgoulias, V; Harris, AL; Gatter, KC
      Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation

      CLINICAL & EXPERIMENTAL METASTASIS
    59. BRIASOULIS E; TSOKOS M; FOUNTZILAS G; BAFALOUKOS D; KOSMIDIS P; SAMANTAS E; SKARLOS D; NICOLAIDES C; PAVLIDIS N
      BCL2 AND P53 PROTEIN EXPRESSION IN METASTATIC CARCINOMA OF UNKNOWN PRIMARY ORIGIN - BIOLOGICAL AND CLINICAL IMPLICATIONS - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY

      Anticancer research
    60. KALOGERAFOUNTZILA A; KOSMIDIS P; BACOYIANNIS C; NICOLAOU A; SAMANTAS E; BRIASSOULIS E; PAVLIDIS N; SKARLOS D; DANILIDIS J; FOUNTZILAS G
      PROGNOSTIC FACTORS INFLUENCING COMPLETE RESPONSE TO TREATMENT AND SURVIVAL OF PATIENTS WITH NASOPHARYNGEAL CANCER

      Anticancer research
    61. Economopoulos, T; Fountzilas, G; Kostourou, A; Danilidis, J; Pavlidis, N; Andreopoulou, H; Nicolaou, A; Papageorgiou, E; Mellou, S; Dervenoulas, J; Stathakis, N
      Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: A clinicopathological comparison between tonsillar and non tonsillar lymphomas

      ANTICANCER RESEARCH
    62. Giatromanolaki, A; Koukourakis, M; Zaramboukas, T; Skordalaki, A; Arapantoni, P; Georgoulias, V; Fountzilas, G
      p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy

      ANTICANCER RESEARCH
    63. VOGT HG; MARTIN T; CAPIZZELLO A; KOLOTAS C; HEY S; SCHNEIDER L; DORNOFF W; FOUNTZILAS G; TEMPLIN T; KETTNER P; ZAMBOGLOU N
      CONCURRENT PACLITAXEL AND RADIOTHERAPY - TREATMENT FEASIBILITY STUDIES

      Strahlentherapie und Onkologie
    64. ABE O; ABE R; ENOMOTO K; KIKUCHI K; KOYAMA H; NOMURA Y; SAKAI K; SUGIMACHI K; TOMINAGA T; UCHINO J; YOSHIDA M; BENRAADT J; VANDEVELDE AO; VANDONGEN JA; VERMORKEN JB; GIOKAS G; LISSAIOS B; HARVEY VJ; HOLDAWAY TM; KAY RG; MASON BH; COATES A; FORBES JF; FOCAN C; LOBELLE JP; GATES GD; POWELL J; DURAND M; MAURIAC L; BARTHOLOMEUS S; PICCART MJ; GELMAN RS; HENDERSON IC; SHAPIRO CL; HANCOCK AK; MASOOD MB; PARKER D; PRICE JJ; JACKSON S; RAGAZ J; DELOZIER T; MACELESECH J; HAYBITTLE JL; BERRY D; BROADWATER G; CIRRINCIONE C; MUSS H; NORTON L; BAUM M; HOUGHTON J; RILEY D; DENT DM; GUDGEON CA; HACKING A; GORDON NH; DAVIS HL; ROMESTAING P; LEHINGUE Y; OWEN JR; MEIER P; HOWELL A; RIBEIRO GC; SWINDELL R; ALBANO J; DEOLIVEIRA CF; GERVASIO H; GORDILHO J; CARSTENSEN B; PALSHOF T; JOHANSEN H; KORZENIOWSKI S; SKOLYSZEWSKI J; PORTNOJ SM; ANDERSEN KW; AXELSSON CK; BLICHERTTOFT M; MOURIDSEN HT; OVERGAARD M; ROSE C; CORCORAN N; TRAMPISCH HJ; COMIS RL; DAVIDSON NE; GRAY R; ROBERT N; TORMEY DC; WOOD W; CHETTY U; FORREST P; JACK W; ROSSBACH J; SYLVESTER RJ; VANDEVELDE CJH; CUNNINGHAM MP; BONNETERRE J; FUMOLEAU P; NAMER M; BASTERT G; RAUSCHECKER H; SAUER R; SAUERBREI W; SCHAUER A; SCHUMACHER M; DESCHRYVER A; BELFIGLIO M; MARI E; NICOLUCCI A; SCORPIGLIONE N; YOSEF HMA; MCARDLE CS; SMITH DC; LARA PC; BOCCARDO F; RUBAGOTTI A; ERAZO A; MEDINA JY; IZUO M; MORISHITA Y; BENTLEY A; DORAN Z; FENTIMAN IS; HAYWARD JL; RUBENS RD; KAUFMANN M; JONAT W; SCHEURLEN H; VONFOURNIER D; FOUNTZILAS G; KLAFSTROM P; BLOMQVIST C; CUZICK J; MARGREITER R; CASTIGLIONE M; CAVILLI F; COLLINS J; FORBES J; GELBER RD; GOLDHIRSCH A; LINDTNER J; PRICE KN; RUDENSTAM CM; SENN HJ; BLISS JM; CHILVERS CED; COOMBES RC; MARTY M; BOROVIK R; BRUFMAN G; HAYAT H; ROBINSON E; WIGLER N; PANNUTI F; TAKASHIMA S; YASUTOMI T; SONOO H; YAMASHITA J; OGAWA M; WELVAART K; HUPPERETS PSGJ; BONTE J; TENGRUP I; TENNVALLNITTBY L; MARTIN P; ROMAIN S; INGLE JN; SUMAN VJ; BUZDAR AU; SMITH T; HAKES T; WITTES R; DELAHUERTA R; SAINZ MG; BONADONNA G; DELVECCHIO M; VALAGUSSA P; VERONESI U; DUBOIS JB; BIANCO AR; LIPPMAN ME; PIERCE LJ; SIMON R; STEINBERG SM; MYLES JD; PATER JL; PRITCHARD KI; ANDERSON S; BROWN A; BRYANT J; COSTANTINO J; DIGNAM J; FISHER B; REDMOND C; WIEAND S; WOLMARK N; JACKSON IM; PALMER MK; BENGTSSON NO; LARSSON LG; LYTHGOE JP; KISSIN M; HANNISDAL E; VARHAUG JE; NISSENMEYER R; BLAMEY RW; MITCHELL AK; ROBERTSON JFR; UEO H; MATHE G; MISSET JL; ABUZAHRA HT; CLARKE EA; MCLAUGHLIN JR; CLARK RM; LEVINE M; MORIMOTO K; SAWA K; TAKATSUKA Y; GUNDERSEN S; HAUERJENSEN M; HOST H; CROSSLEY E; HARRIS A; BEIGHTON A; CLARKE M; COLLINS R; DAVIES C; EVANS V; GODWIN J; GREAVES E; HARWOOD C; JACKSON D; JAMES S; LAU E; MEAD G; NAUGHTEN A; PETO R; TOOTH A; RAMBERT P; ASSELAIN B; SALMON RJ; VILCOQ JR; ARRIAGADA R; HILL C; LAPLANCHE A; LE MG; SPIELMANN M; COCCONI G; DIBLASIO B; CATALANO R; CREECH RH; BROCKSCHMIDT J; COOPER MR; ANDRYSEK O; BARKMANOVA J; FALKSON CI; ABRAHAM M; KLIJN JGM; TREURNIETDONKER AD; VANPUTTEN WLJ; EASTON D; POWLES TJ; GAZET JC; SEMIGLAZOV V; DESHPANDE N; DIMARTINO L; DOUGLAS P; LINDTNER A; NOTTER G; BRYANT AJS; EWING GH; KRUSHENKOSLOSKI JL; GEORGE WD; GOULD A; STEWART HJ; STRONER P; MOLLER TR; RYDEN S; CARSTENSEN J; HATSCHEK T; SODERBERG M; CARPENTER JT; ALBAIN K; CROWLEY J; GREEN S; MARTINO S; OSBORNE CK; RAVDIN PM; RUTQVIST LE; WALLGREN A; HOLM LE; THURLIMANN B; BRENNER H; HERCBERGS A; YOSHIMOTO M; DEBOER G; PATERSON AHG; MEAKIN JW; PANZARELLA T; NAJA A; BAHI J; REID M; SPITTLE M; SENANAYAKE F; BERGH J; HOLMBERG L; SEVELDA P; ZIELINSKY CC; GNANT M; JAKESZ R; BUCHANAN RB; CROSS M; DUNN JA; GILLESPIE WM; KELLY K; MORRISON JM; LITTON A; CHLEBOWSKI RT; BEZWODA WR; CAFFIER H
      POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS

      Lancet
    65. DIMOPOULOS MA; PAPADOPOULOU M; ANDREOPOULOU E; PAPADIMITRIOU C; PAVLIDIS N; ARAVANTINOS G; ASPROPOTAMITIS A; ANAGNOSTOPOULOS A; FOUNTZILAS G; MICHALAS S; PECTACIDES D
      FAVORABLE OUTCOME OF OVARIAN GERM-CELL MALIGNANCIES TREATED WITH CISPLATIN OR CARBOPLATIN-BASED CHEMOTHERAPY - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY

      Gynecologic oncology (Print)
    66. TSAVARIS N; FOUNTZILAS G; MYLONAKIS N; ATHANASSIADIS A; KOSMAS C; KARAKOUSIS C; BACOYIANNIS C; KOSMIDIS P
      A RANDOMIZED COMPARATIVE-STUDY OF ANTIEMETIC PROPHYLAXIS WITH ONDANSENTRON IN A SINGLE 32-MG LOADING DOSE VERSUS 8 MG EVERY 6 H IN PATIENTSUNDERGOING CISPLATIN-BASED CHEMOTHERAPY

      Oncology
    67. NICOLAIDES C; FOUNTZILAS G; ZOUMBOS N; SKARLOS D; KOSMIDIS P; PECTASIDES D; KARABELIS A; GIANNAKAKIS T; SYMEONIDIS A; PAPADOPOULOS A; ANTONIOU F; PAVLIDIS N
      DIFFUSE LARGE-CELL LYMPHOMAS - IDENTIFICATION OF PROGNOSTIC FACTORS AND VALIDATION OF THE INTERNATIONAL NON-HODGKINS-LYMPHOMA PROGNOSTIC INDEX - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY

      Oncology
    68. BRIASOULIS E; TSAVARIS N; FOUNTZILAS G; ATHANASIADIS A; KOSMIDIS P; BAFALOUKOS D; SAMANTAS E; PAVLIDIS N
      COMBINATION REGIMEN WITH CARBOPLATIN, EPIRUBICIN AND ETOPOSIDE IN METASTATIC CARCINOMAS OF UNKNOWN PRIMARY SITE - A HELLENIC COOPERATIVE ONCOLOGY GROUP PHASE-II STUDY

      Oncology
    69. BAFALOUKOS D; FOUNTZILAS G; SKARLOS D; PAVLIDIS N; BAKOYIANNIS C; KARVOUNIS N; KOSMIDIS P
      SUBCUTANEOUS LOW-DOSES OF INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA WITH CARBOPLATIN AND VINBLASTINE IN PATIENTS WITH ADVANCED MELANOMA

      Oncology
    70. STATHOPOULOS GP; RIGATOS S; PAPAKOSTAS P; FOUNTZILAS G
      EFFECTIVENESS OF PACLITAXEL AND CARBOPLATIN COMBINATION IN HEAVILY PRETREATED PATIENTS WITH HEAD AND NECK CANCERS

      European journal of cancer
    71. FOUNTZILAS G; ATHANASSIADIS A; KALOGERAFOUNTZILA A; ARAVANTINOS G; BAFALOUKOS D; BRIASOULIS E; DOMBROS N; IOANNIDIS I; PAVLIDIS N; KOSMIDIS P; SKARLOS D
      PACLITAXEL BY 3-H INFUSION AND CARBOPLATIN IN ANTHRACYCLINE-RESISTANTADVANCED BREAST-CANCER - A PHASE-II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP

      European journal of cancer
    72. ARAVANTINOS G; SKARLOS DV; KOSMIDIS P; ATHANASSIADES A; BAFALOUKOS D; GIANNAKAKIS T; KARPATHIOS S; FOUNTZILAS G
      A PHASE-II STUDY OF PACLITAXEL IN PLATINUM PRETREATED OVARIAN-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY

      European journal of cancer
    73. KOSMIDIS P; BAFALOUKOS D; SKARLOS D; PAVLIDIS N; ARAVANTINOS G; ATHANASIADIS A; KARPATHIOS S; FOUNTZILAS G
      INTRAPERITONEAL (IP) INTERFERON A2B (INF) CONSOLIDATION IN CCR OVARIAN-CANCER (OC) PATIENTS FOLLOWING CARBOPLATIN CHEMOTHERAPY (CT)

      European journal of cancer
    74. BAFALOUKOS D; FOUNTZILAS G; SEMOGLOU C; VASILAKI V; KOSMIDIS P
      PREDICTORS OF LONG-TERM SURVIVAL IN STAGE IV MALIGNANT-MELANOMA (MM) PATIENTS

      European journal of cancer
    75. ECONOMOPOULOS T; FOUNTZILAS G; KOSTOUROU A; DANIELIDIS J; PAVLIDIS N; ANDREOPOULOU E; NICOLAOU A; MELLOU S; DERVENOULAS J; STATHAKIS N
      PRIMARY EXTRANODAL NON-HODGKINS-LYMPHOMA OF THE HEAD AND NECK (HN-NHL)

      European journal of cancer
    76. KOSMIDIS PA; MYLONAKIS N; FOUNTZILAS G; SAMANTAS E; ATHANASIADIS A; ANDREOPOULOU E; PAVLIDIS N; SKARLOS D
      PACLITAXEL AND CARBOPLATIN IN INOPERABLE NON-SMALL-CELL LUNG-CANCER -A PHASE-II STUDY

      Annals of oncology
    77. FOUNTZILAS G; SKARLOS D; ATHANASSIADES A; KALOGERAFOUNTZILA A; SAMANTAS E; BACOYIANNIS C; NICOLAOU A; DOMBROS N; BRIASOULIS E; DINOPOULOU M; STATHOPOULOS G; PAVLIDIS N; KOSMIDIS P; DANIILIDIS J
      PACLITAXEL BY 3-HOUR INFUSION AND CARBOPLATIN IN ADVANCED-CARCINOMA OF NASOPHARYNX AND OTHER SITES OF THE HEAD AND NECK - A PHASE-II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP

      Annals of oncology
    78. KOSMIDIS PA; BACOYIANNIS C; FOUNTZILAS G; ARAVANTINOS G; TSAVARIS N; MILATHIANAKIS C; SKARLOS D
      5-FLUOROURACIL, INTERFERON-ALPHA-2B AND CISPLATIN (FAP) FOR ADVANCED UROTHELIAL CANCER - A PHASE-II STUDY

      Annals of oncology
    79. BRUFMAN G; COLAJORI E; GHILEZAN N; LASSUS M; MARTONI A; PEREVODCHIKOVA N; TOSELLO C; VIARO D; ZIELINSKI C; KRAINER M; SALZER H; SCHULLER J; DITTRICH C; SCHEITHAUER W; ZAMAGNI C; AMBROSINI G; COLUCCI G; GENTILINI P; ZANIBONI A; PACINI P; BIANCO R; MUSTACCHI G; DAPRILE M; DEMATTEIS A; OLIVEIRA C; JORDAAN J; GUDGEON A; VANZYL J; RAKOWSKY E; INBAR M; RATH P; COHEN Y; SHANI A; FRIED G; HEGG R; NETO AB; BADER G; BRAGA RF; VITOC C; PUERTO VML; VALLE AE; SALAZAR JD; SANCHEZ JC; VILLELA GM; FOUNTZILAS G
      DOUBLING EPIRUBICIN DOSE INTENSITY (100 MG M(2) VERSUS 50 MG/M(2)) INTHE FEC REGIMEN SIGNIFICANTLY INCREASES RESPONSE RATES - AN INTERNATIONAL RANDOMIZED PHASE-III STUDY IN METASTATIC BREAST-CANCER/

      Annals of oncology
    80. FOUNTZILAS G; ATHANASSIADES A; GIANNAKAKIS T; BRIASOULIS E; BAFALOUKOS D; KALOGERAFOUNTZILA A; ONIENAOUM A; KALOFONOS H; PECTASIDES D; ANDREOPOULOU E; BAMIA C; KOSMIDIS P; PAVLIDIS N; SKARLOS D
      A RANDOMIZED STUDY OF EPIRUBICIN MONOTHERAPY EVERY 4 OR EVERY 2 WEEKSIN ADVANCED BREAST-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY

      Annals of oncology
    81. NICOLAIDES C; KLOUVAS G; FOUNTZILAS G; ATHANASSIADIS A; SKARLOS D; SAMANTAS E; KOSMIDIS P; MYLONAKIS N; PAVLIDIS N
      INTENSIFIED CARBOPLATIN REGIMEN WITH GM-CSF SUPPORT IN NONSMALL CELL LUNG-CANCER (NSCLC) - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY (HECOG)

      Journal of experimental & clinical cancer research
    82. SKARLOS DV; ARAVANTINOS G; LINARDOU E; KOSTAKOPOULOS CA; KASTRIOTIS I; CHRISTODOULOU C; PICRAMENOS D; GIANNAKAKIS T; DIMOPOULOS K; FOUNTZILAS G
      CHEMOTHERAPY WITH METHOTREXATE, VINBLASTINE, EPIRUBICIN AND CARBOPLATIN (CARBO-MVE) IN TRANSITIONAL-CELL UROTHELIAL CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY

      European urology
    83. FOUNTZILAS G; ATHANASSIADIS A; NIKOLAOU A; KALOGERAFOUNTZILA A; TZITZIKAS J; SAMANTAS E; SKARLOS D; ZAMBOGLOU N; DANIILIDIS J
      ACCELERATED BIFRACTIONATED RADIATION WITH CONCURRENT CISPLATIN ADMINISTRATION IN LOCALLY ADVANCED HEAD AND NECK-CANCER - A FEASIBILITY STUDY

      Tumori
    84. FOUNTZILAS G; KARAVELIS A; MAKRANTONAKIS P; SELVIARIDIS P; TZITZIKAS J; KALOGERAFOUNTZILA A; HATZIBALOGLOU A; KARKAVELAS G; FOROGLOU G; TOURKANTONIS A
      CONCURRENT RADIATION AND INTRACAROTID CISPLATIN INFUSION IN MALIGNANTGLIOMAS - A FEASIBILITY STUDY

      American journal of clinical oncology
    85. FOUNTZILAS G; VASILAROS S; KOUKOURAS D; MALAMOS N; PECTASIDES D; ADAMOU A; NENOPOULOU E; KIRIAKOU K; ZOUVANI I; KATSOHIS K; KAPPAS A; SKOPA C; SEMOGLOU C; FAHANTIDIS E; KONSTANTARAS C; VASILAKI E; ECONOMOPOULOS T; BACOYIANNIS H; BAFALOUKOS D; RAZI E; POLICHRONIS A; ANDROULAKIS G; PAPAIOANNOU T; PAVLIDIS N; SKARLOS D; KOSMIDIS P
      PROGNOSTIC VARIABLES IN CREEK PATIENTS WITH STAGE-II BREAST-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY

      Anticancer research
    86. FOUNTZILAS G; KOSMIDIS P; AVRAMIDIS V; NIKOLAOU A; KALOGERAFOUNTZILA A; MAKRANTONAKIS P; BACOYIANNIS C; SAMANTAS E; SKARLOS D; DANIILIDIS J
      LONG-TERM SURVIVAL-DATA AND PROGNOSTIC FACTORS OF A COMPLETE RESPONSETO CHEMOTHERAPY IN PATIENTS WITH HEAD AND NECK-CANCER TREATED WITH PLATINUM-BASED INDUCTION CHEMOTHERAPY - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY

      Medical and pediatric oncology
    87. FOUNTZILAS G; ATHANASSIADES A; KALOGERAFOUNTZILA A; SAMANTAS E; BACOYIANNIS C; BRIASSOULIS E; PAVLIDIS N; KOSMIDIS P; SKARLOS D
      PACLITAXEL IN COMBINATION WITH CARBOPLATIN OR GEMCITABINE FOR THE TREATMENT OF ADVANCED HEAD AND NECK-CANCER

      Seminars in oncology
    88. SKARLOS DV; ARAVANTINOS G; KOSMIDIS P; ATHANASSIADIS A; STATHOPOULOS GP; PAVLIDIS N; BAFALOUKOS D; KARPHATHIOS S; PAPAKOSTAS P; BAMIA C; FOUNTZILAS G
      PACLITAXEL WITH CARBOPLATIN VERSUS PACLITAXEL WITH CARBOPLATIN ALTERNATING WITH CISPLATIN AS FIRST-LINE CHEMOTHERAPY IN ADVANCED EPITHELIALOVARIAN-CANCER - PRELIMINARY-RESULTS OF A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY

      Seminars in oncology
    89. KOSMIDIS P; MYLONAKIS N; FOUNTZILAS G; SAMANTAS E; ATHANASSIADIS A; PAVLIDIS N; SKARLOS D
      PACLITAXEL (175 MG M(2)) PLUS CARBOPLATIN VERSUS PACLITAXEL (225 MG/M(2)) PLUS CARBOPLATIN IN NONSMALL CELL LUNG-CANCER - A RANDOMIZED STUDY/

      Seminars in oncology
    90. FOUNTZILAS G; ATHANASSIADIS A; SAMANTAS E; SKARLOS D; KALOGERAFOUNTZILA A; NIKOLAOU A; BACOYIANNIS H; STATHOPOULOS G; KOSMIDIS P; DANIILIDIS J
      PACLITAXEL AND CARBOPLATIN IN RECURRENT OR METASTATIC HEAD AND NECK-CANCER - A PHASE-II STUDY

      Seminars in oncology
    91. DANIILIDIS M; FOUNTZILAS G; FLEVA A; DANIILIDIS J; TOURKANTONIS A
      HAPLOTYPES OF HUMAN-LEUKOCYTE ANTIGENS AMONG PATIENTS WITH NASOPHARYNGEAL CANCER IN GREECE

      Oncology
    92. SKARLOS DV; ARAVANTINOS G; KOSMIDIS P; PAVLIDIS N; GENNATAS K; BEER M; MYLONAKIS N; MAKRANTONAKIS P; KLOUVAS G; KARPATHIOS S; LINARDOU H; KONSTANTARAS C; FOUNTZILAS G
      CARBOPLATIN ALONE COMPARED WITH ITS COMBINATION WITH EPIRUBICIN AND CYCLOPHOSPHAMIDE IN UNTREATED ADVANCED EPITHELIAL OVARIAN-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY

      European journal of cancer
    93. FOUNTZILAS G; ATHANASSIADES A; GIANNAKAKIS T; BAFALOUKOS D; KARAKOUSIS K; DOMBROS N; KOSMIDIS P; SKARLOS D
      A PHASE-II STUDY OF PACLITAXEL IN ADVANCED BREAST-CANCER RESISTANT TOANTHRACYCLINES

      European journal of cancer
    94. GOSSIOS K; NIKOLAIDES C; BAI M; FOUNTZILAS G
      WIDESPREAD CASTLEMAN-DISEASE - CT FINDINGS

      European radiology
    95. KOSMIDIS P; MYLONAKIS N; FOUNTZILAS G; PAVLIDIS N; SAMANTAS E; KARABELIS A; KATTIS K; SKARLOS D
      A PROSPECTIVE RANDOMIZED PHASE-III STUDY IN NON-SMALL-CELL LUNG-CANCER COMPARING CISPLATIN, IFOSFAMIDE, VINBLASTINE (VIP) VERSUS CISPLATIN,IFOSFAMIDE AND ETOPOSIDE (VIP-16)

      Annals of oncology
    96. FOUNTZILAS G; KOSMIDIS P; SRIDHAR KS; KALOGERAFOUNTZILA A; BANIS K; DIMITRIADIS A; AVRAMIDIS V; NIKOLAOU A; ZARAMBOUKAS T; SKARLOS D; VRITSIOS A; DANIILIDIS I
      CISPLATIN AND CONTINUOUS-INFUSION OF FLUOROURACIL FOLLOWED BY RADIATION AND WEEKLY CARBOPLATIN IN THE TREATMENT OF LOCALLY ADVANCED HEAD AND NECK-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY

      Cancer investigation
    97. KOSMIDIS PA; TSAVARIS N; SKARLOS D; THEOCHARIS D; SAMANTAS E; PAVLIDIS N; BRIASSOULIS E; FOUNTZILAS G
      FLUOROURACIL AND LEUCOVORIN WITH OR WITHOUT INTERFERON ALFA-2B IN ADVANCED COLORECTAL-CANCER - ANALYSIS OF A PROSPECTIVE RANDOMIZED PHASE-III TRIAL

      Journal of clinical oncology
    98. CVITKOVIC E; ESCHWEGE F; RAHAL M; DOSEN; MERSIC Z; KRAJINA Z; ARMAND JP; BOUHRIS J; TUBIANAMATHIEU M; FOUNTZILAS G; KOSMIDIS PA; PRASAD U; GANESAN S; ELGUEDDARI B; BACHOUCHI M; MANSOURI A; OLIVEIRA J; RAPOSO J; WIERZBICKI R; LIANES P; PENA C; ONAT H; ALTUN M; BENHAMOU E; DUCOURTIEUX M; AZLI N; FANDI A; TAAMMA A; BOSQ J; KLIJANIENKO J; SIGAL R; HONG WK; VOKES EE; CLARK JR; LEFLOCH O; BERNIER J
      PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING NEOADJUVANT CHEMOTHERAPY (CISPLATIN, EPIRUBICIN, BLEOMYCIN) PLUS RADIOTHERAPY VS RADIOTHERAPY ALONE IN STAGE-IV (GREATER-THAN-OR-EQUAL-TO-N2, M0) UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA - A POSITIVE EFFECT ON PROGRESSION-FREESURVIVAL

      International journal of radiation oncology, biology, physics
    99. PECTASIDES D; PAVLIDIS N; GOGOU L; ANTONIOU F; NICOLAIDES C; TSIKALAKIS D; FOUNTZILAS G
      CLINICAL-VALUE OF CA-15-3, MUCIN-LIKE CARCINOMA-ASSOCIATED ANTIGEN, TUMOR POLYPEPTIDE ANTIGEN, AND CARCINOEMBRYONIC ANTIGEN IN MONITORING EARLY BREAST-CANCER PATIENTS

      American journal of clinical oncology
    100. BAFALOUKOS D; PAVLIDIS N; FOUNTZILAS G; SKARLOS D; KLOUVAS G; MAKRANTONAKIS P; GIANNAKAKIS T; TSAVARIS N; KOSMIDIS P
      RECOMBINANT INTERFERON ALFA-2A IN COMBINATION WITH CARBOPLATIN, VINBLASTINE, AND BLEOMYCIN IN THE TREATMENT OF ADVANCED MALIGNANT-MELANOMA

      American journal of clinical oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 14/08/20 alle ore 11:03:35